Century Therapeutics IPSC
NASDAQ IPSC
$1.60 -0.01 (-0.62%)
As of: Oct 22, 2026 · 1:08 PM EDT

Century Therapeutics (IPSC) EBT Margin (2022 - 2025)

Updated

Century Therapeutics (IPSC) posted EBT Margin of -8.84% for FY2025, up 1884.86 percentage points from -1893.70% in FY2024.

Analysis

Century Therapeutics (IPSC) EBT Margin (2022 - 2025) Analysis & Trends

Since FY2022, Century Therapeutics has reported EBT Margin for 4 years.

  • Annual EBT Margin shows a three-year change of +2507.82 percentage points (FY2022 to FY2025).
  • Business Quant data shows IPSC's EBT Margin at -1893.70% in FY2024 (+4137.26 pp), -6030.96% in FY2023 (-3514.30 pp) and -2516.66% in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,166.97 Bn 1,135.56 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 644.38 Bn 564.24 Bn 17.30 Bn 0.13%
3 AbbVie 501.54 Bn 474.65 Bn 12.70 Bn 25.18%
4 Merck 359.36 Bn 313.74 Bn 12.21 Bn -4.11%
5 Novartis Ag 302.13 Bn 266.12 Bn 11.24 Bn 29.63%
6 Astrazeneca 267.59 Bn 241.28 Bn 12.86 Bn 18.19%
7 Amgen 241.49 Bn 196.89 Bn 7.24 Bn 27.53%
8 Gilead Sciences 192.85 Bn 167.05 Bn 6.22 Bn -131.41%
9 Pfizer 171.77 Bn 118.41 Bn 10.94 Bn -4.34%
10 Century Therapeutics 329.25 Mn -175.13 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 70.13%
Dec 31, 2024 -821.88%
Sep 30, 2024 -3,948.67%
Jun 30, 2024 -4,044.75%
Mar 31, 2024 -3,281.99%
Dec 31, 2023 -15,025.00%
Sep 30, 2023 -21,708.11%
Jun 30, 2023 -32,667.68%
Mar 31, 2023 -1,747.44%
Dec 31, 2022 -6,074.86%
Sep 30, 2022 -1,381.47%
Jun 30, 2022 -2,218.48%
Mar 31, 2022 -3,544.14%
API Access

Century Therapeutics EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=IPSC&period=max&api_key=YOUR_API_KEY